المؤلفون: Alasdair J. Coles, Douglas L. Arnold, Ann D. Bass, Aaron L. Boster, D. Alastair S. Compston, Óscar Fernández, Eva Kubala Havrdová, Kunio Nakamura, Anthony Traboulsee, Tjalf Ziemssen, Alan Jacobs, David H. Margolin, Xiaobi Huang, Nadia Daizadeh, Madalina C. Chirieac, Krzysztof W. Selmaj

المصدر: Therapeutic Advances in Neurological Disorders, Vol 14 (2021)

مصطلحات موضوعية: Neurology. Diseases of the nervous system, RC346-429

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1756-2864

URL الوصول: https://doaj.org/article/0fa2ae77784345bda11b4afff0c00fe1

المؤلفون: Alasdair J. Coles (10696403), Douglas L. Arnold (8832665), Ann D. Bass (10696406), Aaron L. Boster (10696409), D. Alastair S. Compston (10696412), Óscar Fernández (3684697), Eva Kubala Havrdová (10696415), Kunio Nakamura (786431), Anthony Traboulsee (194541), Tjalf Ziemssen (352981), Alan Jacobs (8042798), David H. Margolin (10696418), Xiaobi Huang (10696421), Nadia Daizadeh (3968150), Madalina C. Chirieac (10696424), Krzysztof W. Selmaj (10696427)

مصطلحات موضوعية: Neurology and Neuromuscular Diseases, Pharmacology and Pharmaceutical Sciences not elsewhere classified, alemtuzumab, brain volume, CD52, disability, disease activity, efficacy, extension, MRI, multiple sclerosis, relapse, safety

Relation: https://figshare.com/articles/journal_contribution/sj-pdf-1-tan-10_1177_1756286420982134_Supplemental_material_for_Efficacy_and_safety_of_alemtuzumab_over_6_years_final_results_of_the_4-year_CARE-MS_extension_trial/14480552

الاتاحة: https://doi.org/10.25384/sage.14480552.v1

المؤلفون: Giancarlo Comi, Raed Alroughani, Aaron L Boster, Ann D Bass, Regina Berkovich, Óscar Fernández, Ho Jin Kim, Volker Limmroth, Jan Lycke, Richard AL Macdonell, Basil Sharrack, Barry A Singer, Patrick Vermersch, Heinz Wiendl, Tjalf Ziemssen, Alan Jacobs, Nadia Daizadeh, Claudio E Rodriguez, Anthony Traboulsee, Darren P. Baker, Ericka M. Bueno, Colin Mitchell, Rebecca L. Orndorff, Valerie P. Zediak

المصدر: Multiple Sclerosis (Houndmills, Basingstoke, England)

مصطلحات موضوعية: safety, medicine.medical_specialty, Multiple Sclerosis, efficacy, Disease activity, 03 medical and health sciences, 0302 clinical medicine, Multiple Sclerosis, Relapsing-Remitting, Recurrence, Internal medicine, medicine, Humans, 030212 general & internal medicine, Alemtuzumab, relapse, business.industry, Multiple sclerosis, Interferon beta-1a, medicine.disease, Clinical neurology, Pooled analysis, Neurology, Relapsing remitting, Neurology (clinical), business, retreatment, Original Research Papers, 030217 neurology & neurosurgery, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5f74ae046391f8852664dc6fc783f1a
https://hdl.handle.net/10668/14739